介入放射学市场机会、成长动力、产业趋势分析与预测 2024 - 2032

2023 年，全球介入放射学市场估值为 281 亿美元，预计 2024 年至 2032 年复合年增长率为 5%，原因是全球慢性病盛行率不断上升，加上对微创手术的需求不断增加。随着癌症、心血管疾病和神经系统疾病等疾病变得越来越普遍，医疗保健提供者正在转向介入放射学技术，这些技术可以提供有效的治疗方案，缩短恢復时间并降低併发症的风险。这种向微创干预的转变提高了患者的舒适度和满意度，进一步推动介入放射学解决方案在临床实践中的采用。介入放射学产业根据产品、应用、最终用途和地区进行细分。

由于血管摄影系统在诊断和治疗血管疾病方面发挥关键作用，因此到 2023 年将获得 61 亿美元的收入。这些先进的影像系统使医疗保健专业人员能够即时观察血管，有助于对动脉瘤和阻塞等疾病进行精确干预。心血管疾病的日益普及和对微创手术的需求正在推动血管摄影系统的采用。随着技术不断发展，提供改进的成像功能，该细分市场可能会保持其在市场上的主导地位。

由于全球心血管疾病盛行率不断上升，心臟病学领域在 2023 年将占据 31% 的份额。介入放射学技术，例如血管成形术和支架置入术，越来越多地用于心臟相关疾病的微创治疗。随着人们对心臟健康的认识不断增强，越来越多的患者寻求先进的治疗方案，对心臟病介入手术的需求正在激增。此外，影像技术和治疗设备的不断创新增强了这些干预措施的有效性，巩固了心臟病学在市场上的领先地位。

北美介入放射学市场到 2023 年将达到 103 亿美元，在先进的医疗基础设施和高水准医疗技术投资的推动下，2024 年至 2032 年期间将以 4.3% 的复合年增长率增长。该地区对研究和开发的重视带来了介入手术的重大创新，提高了患者的治疗效果和手术效率。此外，人口老化的加剧和慢性病盛行率的增加也刺激了对介入放射服务的需求。由于高度重视病患照护和技术进步，北美将成为整体市场成长的核心贡献者。

。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 全球慢性病盛行率上升
    • 成像技术的技术进步
    • 微创手术的需求不断增加
    • 已开发国家老年人口基数不断成长
  • 产业陷阱与挑战
    • 与产品相关的高成本
    • 复杂的监管场景
• 成长潜力分析
• 监管环境
• 技术景观
• 住院病人到门诊病人的转变型态
• 报销场景
• 波特的分析
• PESTEL分析
• 未来市场趋势
• 差距分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

• 主要趋势
• 血管摄影系统
• 超音波成像系统
• CT扫描仪
• 核磁共振系统
• 萤光透视系统
• 切片装置
• 其他产品

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 心臟病学
• 肿瘤学
• 妇科
• 产科
• 泌尿科
• 胃肠病学
• 其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 诊所
• 门诊手术中心
• 其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Agfa-Gevaert Group
• Canon Medical Systems Corporation
• Carestream Health Inc.
• Cook
• Esaote SPA
• Fujifilm Corporation
• GE Healthcare
• Hologic, Inc.
• Koninklijke Philips N. V
• Olympus Corporation
• Samsung Healthcare (Samsung Electronics Co., Ltd.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Shimadzu Corporation
• Siemens Healthineers
• Teleflex Incorporated

The Global Interventional Radiology Market was valued at USD 28.1 billion in 2023 and is projected to exhibit 5% CAGR from 2024 to 2032, driven by the rising prevalence of chronic diseases worldwide, coupled with an increasing demand for minimally invasive procedures. As conditions such as cancer, cardiovascular diseases, and neurological disorders become more common, healthcare providers are turning to interventional radiology techniques that offer effective treatment options with reduced recovery times and lower risk of complications. This shift towards less invasive interventions enhances patient comfort and satisfaction, further propelling the adoption of interventional radiology solutions in clinical practice. The interventional radiology industry is segmented based on product, application, end-use, and region.

The angiography systems segment garnered USD 6.1 billion in 2023 due to its critical role in diagnosing and treating vascular conditions. These advanced imaging systems enable healthcare professionals to visualize blood vessels in real-time, facilitating precise interventions for conditions such as aneurysms and blockages. The growing prevalence of cardiovascular diseases and the demand for minimally invasive procedures are boosting the adoption of angiography systems. As technology continues to evolve, offering improved imaging capabilities, this segment is likely to maintain its dominance in the market.

The cardiology segment held a 31% share in 2023, driven by the rising prevalence of cardiovascular diseases globally. Interventional radiology techniques, such as angioplasty and stenting, are increasingly utilized for minimally invasive treatment of heart-related conditions. As awareness of heart health grows and more patients seek advanced treatment options, the demand for interventional procedures in cardiology is surging. Besides, ongoing innovations in imaging technology and therapeutic devices enhance the effectiveness of these interventions, solidifying cardiology's leading position in the market.

North America interventional radiology market captured USD 10.3 billion in 2023 and will grow at a 4.3% CAGR between 2024 and 2032, fueled by advanced healthcare infrastructure and high levels of investment in medical technology. The region's emphasis on research and development has led to significant innovations in interventional procedures, enhancing patient outcomes and procedural efficiency. Additionally, a growing aging population and increasing prevalence of chronic diseases are fueling demand for interventional radiology services. With a strong focus on patient care and technological advancements, North America will emerge as a central contributor to the overall market growth.

.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic disease worldwide
    • 3.2.1.2 Technological advancements in imaging technology
    • 3.2.1.3 Increasing demand for minimally invasive procedures
    • 3.2.1.4 Growing elderly population base in developed countries
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost associated with product
    • 3.2.2.2 Complex regulatory scenario
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 In-patient to outpatient shift landscape
• 3.7 Reimbursement scenario
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends
• 3.11 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Angiography systems
• 5.3 Ultrasound imaging systems
• 5.4 CT scanners
• 5.5 MRI systems
• 5.6 Fluoroscopy systems
• 5.7 Biopsy devices
• 5.8 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Cardiology
• 6.3 Oncology
• 6.4 Gynecology
• 6.5 Obstetrics
• 6.6 Urology
• 6.7 Gastroenterology
• 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Clinics
• 7.4 Ambulatory surgical centers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Agfa-Gevaert Group
• 9.2 Canon Medical Systems Corporation
• 9.3 Carestream Health Inc.
• 9.4 Cook
• 9.5 Esaote SPA
• 9.6 Fujifilm Corporation
• 9.7 GE Healthcare
• 9.8 Hologic, Inc.
• 9.9 Koninklijke Philips N. V
• 9.10 Olympus Corporation
• 9.11 Samsung Healthcare (Samsung Electronics Co., Ltd.)
• 9.12 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 9.13 Shimadzu Corporation
• 9.14 Siemens Healthineers
• 9.15 Teleflex Incorporated